Smith & Nephew Pays $240M For Integra’s Extremities Business
Integra is divesting its underperforming extremity orthopedics product portfolio to focus on its neurosurgery, surgical instrument and regenerative medicine businesses.
You may also be interested in...
The major orthopedic device makers saw sharp sales declines during the second quarter and remain cautiously optimistic for the rest of 2020.
The UK Competition and Markets Authority has concerns over the impact on the market for ankle replacements that would result from Stryker's planned $4bn acquisition of Wright Medical.
The deal gives Medtronic the exclusive right to acquire Half Moon Medical, a start-up developing a mitral valve repair system to compete with Abbott’s MitraClip.